Empagliflozin as an effective addition to triple therapies

In patients with type 2 diabetes (T2D), a balanced glucose concentration is mainly achieved through drug therapies. If blood glucose control remains poor despite a triple combination of oral hypoglycaemic agents (OHA), treatment becomes challenging. Iranian scientists have evaluated the efficacy of a quadruple hypoglycemic treatment regimen on glycemic indices in patients with inadequately controlled T2D.